Advertisement

Topics

SeeThruEquity Issues Update on NeuroVive Pharmaceutical

08:20 EDT 5 Jul 2017 | FinanzNachrichten

NEW YORK, NY / ACCESSWIRE / July 5, 2017 / SeeThruEquity, a leading independent equity research and corporate access firm focused on small-cap and micro-cap public companies, today announced it has...

Original Article: SeeThruEquity Issues Update on NeuroVive Pharmaceutical

NEXT ARTICLE

More From BioPortfolio on "SeeThruEquity Issues Update on NeuroVive Pharmaceutical"

Advertisement
Quick Search
Advertisement
Advertisement